Kinaxis Inc has announced that Alvogen, a global pharmaceutical company, has selected Kinaxis to create a more connected supply chain to better manage growth. As a result of the partnership, Alvogen will have end-to-end visibility across the entire supply chain and have the capability to manage the network via an integrated planning platform, driving efficiency, agility and improved scalability.
Based in Morristown, New Jersey, Alvogen focuses on developing, manufacturing and selling generic, brand, over the counter (OTC) and biosimilar products for patients around the world.
“Alvogen’s purpose as an organisation is to make people’s lives better by producing high-quality medicines and making them more accessible to those who might otherwise not be able to afford them,” said Stephen Fecho, US Vice President, Supply Chain & Third Party Operations at Alvogen. “To bring this purpose to life, we need a supply chain that offers complete visibility, and enables us to be more responsive to global change and disruption. We selected Kinaxis RapidResponse as a result of its ability to deliver a proven integrated planning platform with the ability to quickly realize business benefits.”
The always-on capabilities of RapidResponse gives Alvogen the confidence in its decision-making while improving the trust and transparency within the supply chain. This helps to reduce inefficiencies, costs and the chance of obsolescent products as well as streamline operations across its complex global supply chain. Additionally, Kinaxis will help Alvogen effectively manage its new product introduction and tender processes to determine project feasibility and impact across the supply chain.
